Jamie L. Reynoso - 14 Dec 2025 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Signature
/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso
Issuer symbol
CLOV
Transactions as of
14 Dec 2025
Net transactions value
-$57,397
Form type
4
Filing time
16 Dec 2025, 19:59:08 UTC
Previous filing
05 Nov 2025
Next filing
18 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reynoso Jamie L. CEO, Medicare Advantage C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso 16 Dec 2025 0001839066

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability $33,931 -12,567 -0.45% $2.70 2,780,844 14 Dec 2025 Direct F1
transaction CLOV Class A Common Stock Tax liability $23,466 -8,691 -0.31% $2.70 2,772,153 15 Dec 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.
F2 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.